GlassScriptPhysician profile
Frank J Pompo
NPI 1093919805
$4,905.99
in general payments reported to CMS, 2019-2025
22 companies · $928 in 2025
The $928 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $622 · 2020: $238 · 2021: $529 · 2022: $1,812 · 2023: $361 · 2024: $417 · 2025: $928.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,705.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,705.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kairos Surgical INC | $1,419.66 | 2022-2025 | |
| Smith+Nephew, INC. | $1,243.65 | 2021-2025 | Real Intelligence, Evos, Lens 4k |
| Stryker Corporation | $683.10 | 2019-2024 | G-Force, Valor |
| Depuy Synthes Sales INC. | $289.65 | 2019-2025 | Monovisc, Orthovisc |
| Globus Medical, INC. | $156.91 | 2022 | |
| Anika Therapeutics, INC. | $151.23 | 2024 | Integrity |
| Zimmer Biomet Holdings, INC. | $145.89 | 2019-2021 | |
| Biotronik Nro, INC. | $134.04 | 2025 | Prospera |
| Arthrosurface Incorporated | $130.24 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $115.57 | 2019-2024 | Xiaflex |
| Orthofix Medical, INC. | $93.23 | 2023-2024 | Physio-Stim, Accelstim |
| Convatec INC. | $69.45 | 2019-2021 | |
| Bioventus LLC | $56.46 | 2023-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Pacira Pharmaceuticals Incorporated | $50.38 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $36.55 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $33.52 | 2024 | Xiaflex |
| Ultragenyx Pharmaceutical INC. | $23.80 | 2022 | |
| Tactile Systems Technology INC | $18.67 | 2021 | |
| Horizon Therapeutics Plc | $15.09 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.58 | 2022 | |
| Pacira Therapeutics, INC. | $12.84 | 2019 | |
| Sanofi-Aventis U.S. LLC | $11.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Pompo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.